ERIS.NS Forward P/E

The Forward P/E of Eris Lifesciences Ltd (ERIS.NS) is 42.30.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

ERIS.NS Forward P/E - Peers Comparison

Ticker	Name	Value
HIKAL.NS	Hikal Ltd	39.60
ORCHPHARMA.NS	Orchid Pharma Ltd	25.10
INDOCO.NS	Indoco Remedies Ltd	42.55
NEULANDLAB.NS	Neuland Laboratories Ltd	34.74
SUVENPHAR.NS	Suven Pharmaceuticals Ltd	67.20
GRANULES.NS	Granules India Ltd	18.64
STAR.NS	Strides Pharma Science Ltd	15.70
AARTIDRUGS.NS	Aarti Drugs Ltd	12.20
PGHL.NS	Procter & Gamble Health Ltd	38.95
CAPLIPOINT.NS	Caplin Point Laboratories Ltd	25.36
IOLCP.NS	IOL Chemicals and Pharmaceuticals Ltd	19.61
JBCHEPHARM.NS	J B Chemicals and Pharmaceuticals Ltd	31.40
MARKSANS.NS	Marksans Pharma Ltd	22.91
NATCOPHARM.NS	Natco Pharma Ltd	8.91
SHILPAMED.NS	Shilpa Medicare Ltd	26.62
SOLARA.NS	Solara Active Pharma Sciences Ltd	18.66